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Abstract
Background: The self-management of osteoarthritis (OA) and low back pain (LBP) through activity and skills
(SOLAS) theory-driven group-based complex intervention was developed primarily for the evaluation of its
acceptability to patients and physiotherapists and the feasibility of trial procedures, to inform the potential for a
definitive trial.
Methods: This assessor-blinded multicentre two-arm parallel cluster randomised controlled feasibility trial
compared the SOLAS intervention to usual individual physiotherapy (UP; pragmatic control group). Patients with
OA of the hip, knee, lumbar spine and/or chronic LBP were recruited in primary care physiotherapy clinics (i.e.
clusters) in Dublin, Ireland, between September 2014 and November 2015. The primary feasibility objectives were
evaluated using quantitative methods and individual telephone interviews with purposive samples of participants
and physiotherapists. A range of secondary outcomes were collected at baseline, 6 weeks (behaviour change only),
2 months and 6 months to explore the preliminary effects of the intervention. Analysis was by intention-to-treat
according to participants’ cluster allocation and involved descriptive analysis of the quantitative data and inductive
thematic analysis of the qualitative interviews. A linear mixed model was used to contrast change over time in
participant secondary outcomes between treatment arms, while adjusting for study waves and clusters.
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Results: Fourteen clusters were recruited (7 per trial arm), each cluster participated in two waves of recruitment,
with the average cluster size below the target of six participants (intervention: mean (SD) = 4.92 (1.31), range 2–7;
UP: mean (SD) = 5.08 (2.43), range 1–9). One hundred twenty participants (83.3% of n = 144 expected) were
recruited (intervention n = 59; UP n = 61), with follow-up data obtained from 80.8% (n = 97) at 6 weeks, 84.2% (n =
101) at 2 months and 71.7% (n = 86) at 6 months. Most participants received treatment as allocated (intervention
n = 49; UP n = 54). The qualitative interviews (12 participants; 10 physiotherapists (PTs) found the intervention and
trial procedures acceptable and appropriate, with minimal feasible adaptations required. Linear mixed methods
showed improvements in most secondary outcomes at 2 and 6 months with small between-group effects.
Conclusions: While the SOLAS intervention and trial procedures were acceptable to participants and PTs, the
recruitment of enough participants is the biggest obstacle to a definitive trial.
Trial registration: ISRCTN ISRCTN49875385. Registered on 26 March 2014.
Keywords: Complex group intervention, Feasibility cluster randomised controlled trial, Self-management, Behaviour
change intervention, Qualitative methods, Intervention mapping, Osteoarthritis, Low back pain, Physiotherapists,
Primary care
Introduction
The successful implementation of a standardised,
evidence-based group programme to support self-
management (SM) for people with chronic musculoskel-
etal pain is a priority for primary care physiotherapy
(PT) in Ireland [1]. While international clinical guide-
lines endorse self-management, exercise and physical ac-
tivity for osteoarthritis (OA) and low back pain (LBP)
[2–6], the evidence for the effectiveness of existing pro-
grammes is weak, of low quality [7–9] and rarely under-
pinned by behaviour change theory [10, 11]. Additional
local barriers to implementation of these guidelines in
Ireland include the variable quality of the primary care
health system infrastructure and physiotherapy staffing
levels, resulting in most patients with OA and LBP re-
ceiving a plethora of multi-modal individual physiother-
apy approaches from staff with varying levels of
expertise in chronic musculoskeletal pain [1]. We devel-
oped the self-management of OA and chronic LBP
through activity and skills (SOLAS) complex interven-
tion, by adapting an existing intervention (Facilitating
Activity and Self-management in Arthritis, FASA) [12]
through an intervention mapping (IM) process [13].
FASA is a version of the efficacious and cost-effective
ESCAPE-knee pain intervention [14, 15] designed for pa-
tients with OA of the hip, knee and lumbar spine with
proven acceptability in the UK health system [16], and
hence, it was considered a credible prototype for adapta-
tion. The IM process included a needs assessment in-
volving literature reviews, interviews with patients with
OA and LBP and primary care physiotherapists, evalu-
ation of existing primary care physiotherapy resources to
provide a standardised group programme, and a consen-
sus building workshop with physiotherapy stakeholders
to define the SOLAS intervention programme goals,
underpinning behaviour change theory and required
adaptations to FASA to address the needs of patients,
the health service and the evidence [13]. The resultant
SOLAS intervention comprises six weekly sessions of
90-min group education and exercise designed for
people aged at least 45 years with OA of the hip, knee
and/or lumbar spine and those aged at least 30 years
with chronic LBP. This contrasts with the FASA and ES-
CAPE interventions of 12 twice weekly sessions of 60
min intended for adults aged over 50 years with OA
only. SOLAS is also underpinned by self-determination
theory (SDT), which proposes that people have basic
psychological needs for autonomy, competence and re-
latedness, which if satisfied, for example, by the needs
supportive communication style of a physiotherapist will
increase individuals’ autonomous motivation and en-
gagement in our target health behaviours of increased
physical activity (PA) and use of self-management strat-
egies. SOLAS also targets other selected determinants of
SM behaviour, including fear and pain catastrophising in
LBP patients [5, 17–19] identified from our needs assess-
ment, via 31 evidence-based behaviour change tech-
niques (BCTs), defined within the intervention mapping
process, as illustrated in Fig. 1. Consequently, SOLAS is
the first theory-driven, group-based intervention de-
signed for a mixed group of people with OA and/or
chronic LBP (CLBP) that was informed by the needs of
intervention providers and patients to increase its poten-
tial for implementation. Therefore, as endorsed within
the UK Medical Research Council guidelines, the cred-
ibility, acceptability and feasibility of this intervention
warrants investigation prior to testing in a definitive trial
[20].
Aims and objectives
The aim of this cluster feasibility trial [ISRC
TN49875385] was to evaluate the feasibility of providing
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the SOLAS intervention [experimental group] within a
diverse range of primary care PT settings for patients
with OA hip/ knee, lumbar spine and/or CLBP com-
pared to usual individual physiotherapy (UP), which
served as the pragmatic control group in order to inform
its appropriateness for testing in a future definitive trial.
Based on key areas of focus for feasibility studies [21–
24], our primary objectives were (1) to assess the accept-
ability, demand and necessary adaptations of the SOLAS
intervention to participants and physiotherapists in
order to optimise its design, uptake and delivery and (2)
to determine the feasibility of trial recruitment, retention
and follow-up procedures to inform the most efficient
and effective study design for any future definitive trial.
The secondary objectives were to explore the prelimin-
ary effects of the intervention on (3) physical function,
pain, emotional and global wellbeing and (4) the process
model of behaviour change compared to UP. This would
inform any changes to the design of the SOLAS inter-
vention for a future definitive trial.
A comprehensive assessment of the fidelity of inter-
vention delivery, another key component of feasibility
has been reported separately [25–27].
Methods
Design and setting
This was an assessor-blinded multicentre two-arm paral-
lel cluster randomised controlled feasibility trial compar-
ing the SOLAS intervention to UP. A cluster
randomisation was chosen for practical reasons and to
prevent contamination by preference of patient or PT,
with each primary, community and continuing care
clinic (PCCC) serving as the cluster unit. The trial was
conducted in publicly funded outpatient PCCC clinics in
Ireland between September 2014 and June 2016. Ethical
approval was granted by University College Dublin’s Hu-
man Research Ethics Committee (LS-13-54), and the
protocol was approved by the Health Service Executive
(HSE) Primary Care Research Committee in March 2014
and has been published [1] and registered in Current
Controlled Trials [ISRCTN49875385].
Cluster eligibility criteria, randomisation and allocation
concealment
The unit of randomisation was the PCCC clinic. PT
managers in primary care areas in Dublin/North Kildare,
Ireland, were approached for participation in the trial (>
1 clinic per PT manager possible) by the trial manager.
Eligible clinics were identified from the clinics willing to
participate. All potentially eligible clinics must have been
able to provide both interventions and must have
expressed willingness to send staff to the 2-day training
programme required for sites randomised to the SOLAS
intervention. In PCCC clinics that could not provide the
SOLAS intervention on site due to a lack of suitable
gym facilities, a neighbouring community site was used
but all treatment was provided by PCCC clinic physio-
therapists. Randomisation was performed among these
eligible clinics that had confirmed willingness to partici-
pate in the study. The trial manager confirmed eligibility,
willingness and ability to participate with each PT man-
ager the day before randomisation. Eligible clinics, strati-
fied into HSE clinics and community sites, were
randomised by the statistician (RS) using R version 3.02,
using restricted randomisation (permutation) to ensure
balance between arms within strata. The statistician was
blind to clinic identifiers during randomisation and ana-
lysis. The cluster treatment allocations were communi-
cated by the statistician to the trial manager on the day
of randomisation. The trial manager contacted each PT
Fig. 1 Process model of behaviour change in SOLAS intervention
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manager the day after randomisation after all eligibility
had been checked to inform them of the allocation arm
of each of their nominated sites. The PT manager then
communicated the allocation arm with the relevant
physiotherapy staff in each site. Patients were not
approached before randomisation or the completion of
PT training.
Prior to randomisation, eligible PTs in all clusters were
purposively selected by PT managers to participate in
the trial based on affiliation with suitable study sites,
interest, experience and caseload (i.e. working full-time
within chronic musculoskeletal pain service in the nomi-
nated clinic). The trial manager provided all nominated
PTs with a participant information leaflet (i.e. outlined
the rationale for the study and the role of consenting
PTs within the trial but masked them to the feasibility
trial objectives) and an opportunity to ask questions be-
fore obtaining written informed consent and completing
baseline data collection of PT characteristics (including
treatment expectations) prior to cluster randomisation.
Due to the nature of the intervention and the pragmatic
cluster trial design, it was not possible to blind PTs in ei-
ther arm after randomisation.
Participant eligibility criteria
The participant enrolment procedure developed in
consultation with the clinics involved the trial man-
ager (IJ) sending trial information and participant eli-
gibility criteria (see Table 1) to all referring general
practitioners, PTs raising awareness of the trial,
screening waiting lists with the physiotherapy re-
searchers (ET, AK) and sending potentially suitable
referrals an invitation letter. Respondents were con-
tacted by the trial manager and provided with verbal
information about the study, given an opportunity to
ask questions and if interested provisionally screened
for eligibility over the telephone. In order to minimise
selection bias during phone screening, respondents
were requested not to declare their clinic details to
the trial manager. Interested and potentially eligible
participants were then transferred by phone to the
physiotherapy researcher who sent the participant in-
formation leaflet and invitation to the local PCCC
clinic. At the PCCC clinic, written informed consent
for data collection was obtained prior to face-to-face
screening, PT assessment and participants completing
the secondary outcome measures. The participants
were then informed of their treatment allocation
(based on the random allocation of the PCCC clinic)
by the physiotherapy researcher. The reasons for ex-
clusion at each step in the recruitment process were
recorded centrally and reviewed at weekly trial meet-
ings between the principal investigator (DH), trial
manager (IJ) and physiotherapy researchers (ET, AK)
in order to minimise selection bias, particularly dur-
ing face-to-face screening when treatment allocation
was unblinded.
Trial interventions and physiotherapists
Treatment in both arms was provided by Chartered
Physiotherapists from the participating PCCC clinics. In-
terventions pertain to both the cluster and individual
participant level.
Table 1 Eligibility criteria for the feasibility trial
Inclusion criteria
Diagnosis Osteoarthritis
NICE [4] working diagnosis of osteoarthritis of the
hip, knee or lumbar spine defined as:
• Age 45 years old or over, and
• Activity related joint pain and
• Either no morning joint-related stiffness or morn-
ing stiffness that lasts no longer than 30 min
Non-specific low back pain
Aged ≥ 30 years old with non-specific low back
pain of mechanical origin with or without radi-
ation to the lower limb
Symptom duration Chronic (≥ 3 months)
English language Be able to read, understand and speak English
without assistance
Contact status Access to a telephone for screening and
assessment
Availability Available to attend a 6-week start-stop group class
of 1.5 h per week
Exclusion criteria
Pathology Suspected or confirmed serious spinal pathology
(fracture, metastatic, inflammatory or infective
diseases of the spine, cauda equina syndrome/
widespread neurological disorder)
Nerve root compromise (2 of strength, reflex or








Scheduled for major surgery during treatment
Contraindications
Unstable angina / uncontrolled cardiac
dysrhythmias / severe aortic stenosis / acute
systemic infection accompanied by fever
Other No confounding conditions, such as a neurological
disorder, intellectual disorder or unstable
psychiatric condition.
Bladder or bowel incontinence
People who are assessed to be at high risk of falls
Physiotherapy in the preceding 6months
Unable or unwilling to attend
Ongoing litigation related to the pain condition
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SOLAS intervention
Training of physiotherapists PTs (n = 2 per site) ran-
domised to the intervention arm attended 12 h standar-
dised training over 2 days in a Dublin metropolitan
university within 1 month of their scheduled start date
to deliver SOLAS at their clinic. The training
programme introduced PTs to the SOLAS intervention
structure, content, support materials and delivery [1]. Its
effectiveness in successfully supporting PTs to deliver
SOLAS using a needs supportive communication style
has been reported [25].
Intervention Participants were required to attend a 90-
min start-stop 6-week group class in the participating
PCCC clinic or local community centre (if suitable gym
facilities were not available) [1]. Consistent with routine
PT practice and agreed during the intervention develop-
ment phase [13], each group class was scheduled by PTs
to run at the same time for six consecutive weeks during
non-holiday periods in order to optimise participant at-
tendance. The timing of classes was determined by PTs’
experience of providing group classes and the availability
of site facilities, with each class running weekdays either
late morning or early afternoon. As detailed in the trial
protocol, each class comprised of 45 min education/
group discussion on a specific SM topic (i.e. physical ac-
tivity, pacing, healthy eating for lifestyle and balanced
weight, pain management approaches including medica-
tion, pain-coping and relaxation strategies) and 45 min
supervised group exercises (range of general aerobic,
mobilisation and strengthening exercises for the lumbar
spine, hip and knee joints) with PT guidance on exercise
selection [1]. Participants were also provided with sup-
port materials to facilitate their engagement with the
programme (e.g. handbook, pedometer). PTs recorded
the dose of treatment provided and any harms or unin-
tended effects experienced by any participants during
the 6-week class in weekly treatment record forms devel-
oped for the trial (Additional file 1). A group class size
of six participants was agreed with PTs during the
SOLAS intervention development study [13]. Eleven
trained PTs delivered SOLAS within the trial, with three
PTs providing it on two occasions. PTs’ high fidelity to
the delivery of intervention content and support mate-
rials was reported previously [27].
Usual individual physiotherapy
The UP treatment provided in randomised PCCC clinics
was defined as individualised advice/education regarding
PA, prescribed exercise, and lifestyle factors, exercise
therapy and manual therapy at the PT’s discretion. They
were requested not to refer participants to group-based
programmes for pain management during the trial. The
content and dose of treatment provided and any harms
or unintended effects of treatment experienced by any
participants were recorded by PTs in treatment record
forms developed for the trial (Additional file 1); there
was no restriction on the number of visits. Thirteen PTs
delivered treatment in the UP arm.
Outcomes and data collection
The primary feasibility outcomes related to the accept-
ability, demand and necessary adaptations of the SOLAS
intervention and the feasibility of trial recruitment, re-
tention and follow-up procedures to participants and
PTs were evaluated using a range of qualitative and
quantitative methods (Additional file 1). Participant ac-
ceptability of the SOLAS intervention compared to usual
individual physiotherapy included measures of treatment
expectation at baseline, attendance rates during treat-
ment and satisfaction with treatment at follow-up (Add-
itional file 1). The secondary outcomes were assessed
using validated self-report measures of physical function,
pain, emotional and global wellbeing and a range of out-
comes related to the process model of behaviour change.
These measures were collected at baseline/start of treat-
ment and 2 and 6months from baseline/start of treat-
ment, with an additional 6-week follow-up from
baseline/start of treatment included for the behaviour
change outcomes. Follow-up was conducted by tele-
phone with a blinded researcher unless participants pre-
ferred to complete them by post. Non-respondents were
contacted by phone/text message on three occasions
within a 3-day period to invite completion of outcomes,
and if no response was obtained were posted a minimum
data set outcome measure pack inviting completion at
their convenience (Additional file 2).
Sample size
The prespecified sample size consideration for the feasi-
bility trial, as specified in the protocol [1], was to recruit
12 to 14 clusters (PCCC clinics) to test the feasibility of
the intervention across a range of settings with varying
staffing, facilities, equipment and clientele; aiming to re-
cruit a minimum of six clusters in each arm, implement-
ing two waves of recruitment, with at least six
participants in each cluster per wave, for a total sample
of 144 participants (72 per arm). However, a “rule-of-
thumb” recommendation for pilot studies is that 30 par-
ticipants per arm be enrolled to estimate parameters for
future sample size calculations [28]. For the purpose of
our feasibility pilot cluster trial, the sample size consid-
eration was not based on a formal calculation, but rather
on this rule of thumb designed to ensure adequately
precise estimation of parameters including the standard
deviation of our outcome effect sizes. As this rule of
thumb was devised for simple individual-level
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randomised trials, we adjusted it upwards to account for
a cluster design effect to prevent too much loss of preci-
sion. Assuming an intraclass correlation coefficient
(ICC) of 0.03 for our secondary outcomes of physical ac-
tivity, physical function and pain from a previous trial of
a similar population in Ireland’s health system [29], we
adjusted this rule of thumb to 36 participants per arm,
and allowing for 25% loss to follow-up, we aimed to re-
cruit 48 participants per arm (96 in total) to estimate the
sample size for a definitive trial.
The specific a priori feasibility criteria to move to a de-
finitive trial were that:
1) The SOLAS intervention was acceptable to
participants and PTs and necessary adaptations
were achievable
2) It was feasible to deliver the intervention with high
fidelity
3) The recruitment targets of 12 clusters, a cluster size
of six and a sample size of 144 participants were
achieved
4) The recruitment, retention and screening
procedures were successful in identifying the target
population and workable for a larger trial
5) The outcome measures and follow-up procedures
were acceptable to participants and operational in a
larger trial
6) There was evidence of preliminary effects of the
intervention on secondary outcomes and the
theoretical process model of behaviour change
Data analysis
Statistical analysis was by intention to treat according to
participants’ cluster allocation. Quantitative data were
coded and entered into the Statistical Package for the
Social Sciences (IBM SPSS Statistics Version 24). Since
this was a feasibility trial, a priori descriptive analysis of
the quantitative and qualitative data were undertaken to
answer the primary feasibility objectives [1]. Both par-
ticipant and PT interviews were transcribed, anonymised
(ET, IJ) and analysed (DMA, DH, JM) using an inductive
thematic approach (see Additional file 3) [30]. Analysis
of the primary feasibility objective related to trial proce-
dures were undertaken on an interim basis after each
study wave by the research team and used to inform
minor protocol refinements for subsequent waves (see
Additional file 1). Analysis of the secondary outcome
measures was undertaken at the end of the trial and per-
formed by the statistician who remained blinded to
group identification until analysis was complete. A linear
mixed model was used to examine change over time in
participant outcomes between treatment groups, while
adjusting for study waves and clusters. Three-level logis-
tic or linear mixed effects models were fitted using the
MIXED command, with a random intercept for each
participant, and a random intercept for each cluster as a
higher-level effect, using the default Newton-Raphson al-
gorithm for restricted maximum likelihood estimation of
the covariance parameters. Time and group effects, and
an interaction term for time by group, were included in
each model. Treatment effects were reported as model
estimated marginal means with 95% confidence intervals
(CI) or as medians, 1st and 3rd quartile, if skewed or a
substantial floor or ceiling effect was observed. ICCs for
the clusters were calculated for each endpoint. Due to
the multi-joint inclusion of participants with hip, knee
and lumbar spine pain, further exploratory analysis of
the change over time in secondary outcomes within each
of these joint pain areas was undertaken. Estimated mar-
ginal means (or medians) are also reported for each
group at each time-point and mean changes from base-
line to subsequent time-points are reported within
groups, and between-group differences at each time-
point. From logistic models, odds ratios for change from
baseline to each subsequent time-point, and ratios of
odds ratios to contrast the groups are reported.
Results
Recruitment
Details of cluster and participant recruitment and reten-
tion are shown in Fig. 2. In January 2014, 20 clusters
were invited, 18 were eligible and randomised, of which
14 randomised clinics were agreed with PT managers as
available at the start of the trial and proceeded to par-
ticipate in the trial (7 per trial arm). The time lag be-
tween randomisation to trial initiation for the sites
within each arm was: intervention: median = 238 days,
interquartile range (IQR) 232–388 days, range 232 to
391 days; UP: median = 282 days, IQR 273–373 days,
range 233 to 383 days. The reasons for managers with-
drawing consent for 4 clinics participation after random-
isation and treatment allocation were taken for
pragmatic local service reasons unforeseen prior to ran-
domisation and not due to the outcome of randomisa-
tion as outlined in Fig. 2. Each cluster participated in
two waves of recruitment (four clusters participated
in pilot study) resulting in three study waves (W1–
W3) between Autumn 2014 and Autumn 2015 to
support the delivery of the SOLAS intervention dur-
ing non-holiday periods in order to optimise attend-
ance. In total, 120 participants (83.3%; of n = 144
expected) were enrolled (intervention n = 59; UP n =
61). The number of clusters and the number of par-
ticipants recruited in each study wave are detailed in
Table 2. Overall, the average cluster size was below
the target of six participants (intervention: mean
(SD) = 4.9 (1.3), range 2–7; UP: mean (SD) =5.1 (2.4),
range 1–9). Three of 7 sites in the intervention arm
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Fig. 2 CONSORT flowchart edited for cluster and feasibility trials
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had a cluster size of at least six participants com-
pared to 5 of 7 sites in the UP arm. The recruitment
rate in W1 was below target, which resulted in the
addition of two contingency clusters for W2 and W3
and simplification of the participant invitation letter
to increase its readability and clarity to potential
participants, which resulted in an increase in the
overall recruitment rate and mean cluster size in
subsequent waves in the intervention arm.
Between September 2014 and November 2015,
1708 referrals were identified by PTs, with 1136
(66.5%) excluded predominantly due to diagnosis
(n = 784), age (n = 158), symptom duration (n = 53)
and exclusion criteria (n = 133; Fig. 2). In total, 572
invitation letters were sent to potentially eligible par-
ticipants, of which 375 (65.6%) responded, and 224
(59.7%) were excluded by telephone screen mainly
due to preference for individual PT (n = 62), inability
to attend SOLAS group (n = 30), physiotherapy in
past 6 months (n = 22) or poor English (n = 31). Of
the 151 invited to face-to-face screening, 31 (20.5%)
were excluded (nerve root compromise n = 9, non-
attendance n = 12), with 120 consenting participants
recruited, representing 20.9% of invitation letters and
7% of total referrals.
Treatment, attendance and satisfaction
The majority of participants received treatment as allo-
cated (intervention n = 49; UP n = 54), 16 did not receive
any treatment (intervention n = 9; UP n = 7) and one
participant randomised to the intervention arm re-
quested and received individual physiotherapy but
remained in the intervention arm for the ITT analysis.
There were no reported harms or unintended effects of
treatment experienced by participants during the 6-week
treatment period in either arm as recorded in the
treatment record forms. The mean (SD) number of
treatments received in each arm was comparable (inter-
vention 4.3 (1.6); UP 3.8 (1.7); however, the mean (SD)
duration of treatment was longer in the UP arm (7.8
(3.8) weeks) compared to the intervention arm (4.8
(1.6)). Participants in both arms reported positive ratings
for overall physiotherapy care received (Table 3).
PT characteristics were similar between arms (see
Additional file 4). The SOLAS intervention was delivered
12 times across all seven randomised clusters (five of the
seven delivered it twice), in four PCCC clinics and three
local community centres/gyms (see Additional file 5).
Only two sites reached the target class size of 6 partici-
pants, with an overall mean class size of 4.1 (1.2) partici-
pants (min–max 2–6) showing minimal variation
Table 2 Cluster size by study wave, site and treatment arm
Wave SOLAS intervention Usual physiotherapy
Site code Target recruitment Cluster size recruited Site code Target recruitment Cluster size recruited
W1 Autumn 2014 Aa 6 2 H 6 3
B 6 6 Ia 6 7
C 6 4 Ja 6 6
D 6 5 K 6 3
L 6 3
Subtotal 4 24 17 5 30 22
Mean cluster size 4.3 4.4
W2 Spring 2015 B 6 4 H 6 4
C 6 5 K 6 4
D 6 4 L 6 7
Ea 6 7 M 6 6
F 6 6 N 6 8
G 6 5
Subtotal 6 36 31 5 30 29
Mean cluster size 5.2 5.8
W3 Autumn 2015 F 6 6 M 6 1
G 6 5 N 6 9
Subtotal 2 12 11 2 12 10
Mean cluster size 5.5 5.0
Total 7 72 59 7 72 61
aSites that participated in the pilot trial in Spring 2014 [13] participated in one recruitment wave during the feasibility trial
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Over the course of treatment for your hip, knee and/or back pain how satisfied were you with
your overall physiotherapy care in this study?
• Very dissatisfied 1 (3%) 2 (5%)
• Somewhat
dissatisfied
3 (7%) 2 (5%)
• Neither satisfied
nor dissatisfied
1 (3%) 2 (5%)
• Somewhat
satisfied
10 (25%) 5 (12%)
• Very satisfied 25 (62%) 30 (73%)
Do you think the physiotherapy treatment you received in this study benefited your hip, knee
and/or back pain?
• Do not know 1 (2%) 1 (2%)
• No benefit 5 (12%) 4 (10%)
• Some benefit 13 (33%) 16 (38%)
• Great benefit 21 (53%) 21 (50%)
How helpful in reaching your treatment goal was the physiotherapy treatment you received
in this study?
• Do not know 1 (3%) 0 (0%)
• No benefit 3 (7%) 5 (12%)
• Some benefit 16 (40%) 18 (43%)
• Great benefit 20 (50%) 19 (45%)
How helpful was the advice/information you received during physiotherapy treatment in this
study in helping you to manage your hip, knee and/or back pain?
• Do not know 0 (0%) 1 (2%)
• No benefit 1 (3%) 4 (9%)
• Some benefit 12 (29%) 12 (28%)
• Great benefit 28 (68%) 26 (61%)
How easy/difficult has it been for you to stick to your exercise/physical activity programme
since finishing treatment?
• Very difficult 6 (15%) 4 (10%)
• Somewhat difficult 11 (27%) 11 (26%)
• Neither difficult
nor easy
5 (13%) 7 (17%)
• Somewhat easy 13 (32%) 11 (26%)
• Very easy 5 (13%) 9 (21%)
Would you recommend the treatment you received in this study to a relative or friend? • Yes 39 (97%) 38 (88%)
• No 1 (3%) 5 (12%)
Would you be happy to receive this form of treatment again? • Yes 36 (88%) 38 (88%)
• No 5 (12%) 5 (12%)
Acceptability of follow-up procedures
How acceptable was it to you to be asked to complete the outcome measures as part of the
study?
• Very unacceptable 2 (4%) 9 (0%)
• Somewhat
unacceptable
1 (2%) 2 (5%)
• Neither acceptable
nor unacceptable
3 (7%) 3 (7%)
• Somewhat
acceptable
10 (24%) 23 (55%)
• Very acceptable 25 (61%) 14 (33%)
How much of a burden was it to you to complete the outcome measures as part of the
study?
• Do not know 1 (2%) 1 (2%)
• Great burden 2 (5%) 3 (7%)
• Some burden 3 (7%) 9 (21%)
• No burden 35 (86%) 30 (70%)
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between waves. Eleven of 49 participants dropped out
during the intervention for various reasons, but most
participants (57.2%, n = 28) attended at least five classes
corresponding to 83.3% adherence and had a treatment
duration of 6 weeks (n = 27, 55.1%). All UP treatments
were provided within all seven randomised PCCC
clinics; details of treatment provided are in
Additional file 6.
Follow-up procedures
Between October 2014 and June 2016, follow-up data
were obtained from 80.8% (n = 97) of participants at 6
weeks, 84.2% (n = 101) at 2 months and 71.7% (n = 86) at
6 months. The majority of respondents completed
follow-up by phone (see Additional file 7), with the
mean (SD) completion time increasing at each time-
point [6 weeks: 24 (5.2) minutes (min-max 15–35); 2
months: 41 (8.9) minutes (20–60); 6 months: 44 (8.8) mi-
nutes (min-max 25–60)] as questionnaire length also in-
creased. Most 6-month respondents found the follow-up
procedures acceptable (Table 3). There was minimal
missing data and no measure that participants reported
difficulty completing.
Qualitative interviews
Twelve participants who had received the intervention
(8F, 4M; median (min-max) age years = 64.5, 40–79)
were interviewed. Those interviewed had attended a me-
dian (IQR; min-max) of six sessions (1.8; 1–6). Ten of
the 11 PTs who had delivered the intervention were
interviewed. The main findings from the qualitative in-
terviews related to the primary feasibility objectives.
These ranged from the acceptability and demand of the
intervention from the participant and PT perspectives,
as well as the practicality and necessary adaptations to
the intervention, PT training programme and trial re-
cruitment procedures for a future definitive trial. A syn-
opsis of these findings is presented below and supported
by exemplar quotes and the number of individuals
reporting each theme in Additional file 3. The qualitative
studies are reported in accordance with current guide-
lines [31] (see Additional file 8).
SOLAS intervention
Acceptability Participants viewed the overall experience
of engaging with the intervention and resource materials
very positively and had a good understanding that it was
designed to educate them to take a more active role in
managing their chronic musculoskeletal condition. The
social aspect of the group was viewed as a key benefit by
many participants. Similarly, PTs were overtly positive
about their experience of providing the intervention to a
mixed group, reporting it acceptable and feasible to
deliver during the trial and that it addressed a need
within their service and would have relevance for clients
with other musculoskeletal disorders.
Demand Participants reported they were likely to use
some or all of the SM behaviours and related compo-
nents in their daily lives; however, some participants
found goal setting difficult to utilise. Key PT demands
during SOLAS delivery included the volume of educa-
tional content in the first session, the perceived over-
emphasis on goal setting, and striking a balance in their
use of language that provided appropriate direction to
participants while adhering to the principle of autonomy
support. Other challenges included delivering the inter-
vention to a small group and those with inconsistent at-
tendance or lacking motivation to engage in the exercise
programme.
Practicality Despite variations in facilities, gym and
audio-visual equipment, PTs were satisfied that there
were no practical difficulties with intervention delivery.
The recruitment of enough participants was highlighted
as a key issue that would need to be addressed for a fu-
ture definitive trial, with the majority of PTs believing a
class size of six was optimal.
Adaptation Minimal changes were made during deliv-
ery, but a number of PTs made suggestions for future
adaptations, particularly decreasing the educational con-
tent in session 1, potentially reducing the duration of the
education component to 20–25min, delivering the exer-
cise component first and simplifying and adding more
visuals to the handbook for those with lower literacy
levels and limited time to read the materials provided.
Physiotherapist training
All PTs were positive about the training and feedback
provided in preparation for intervention delivery, consid-
ering it acceptable in improving their ability to promote
SM, while also suggesting more specific guidance and
practical examples to support the demand and increase
their confidence in the use of autonomy supportive lan-
guage within a group setting would be beneficial in fu-
ture training.
Trial recruitment procedures
Participants and PTs spoke very positively about their
experience of trial participation. PTs expressed some
concerns about the enrolment of some participants due
to high levels of pain, the strict exclusion criteria and
small catchment areas that limited recruitment numbers,
proposing over-recruitment and the provision of some
pre-group individualised treatment for a definitive trial
to increase uptake.
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Secondary outcome measures and behavioural process
outcomes
Participants’ baseline sociodemographic and clinical
characteristics were comparable between groups (Add-
itional file 9). There were a higher proportion of partici-
pants with a single area of pain (74.1%) than multi-joint
pain (25.9%), with CLBP being the most prevalent diag-
nosis followed by OA knee. Both the intervention and
UP arms were considered credible with similar treat-
ment expectations.
Participant’s baseline secondary outcome (Table 4)
and behavioural process outcome (Additional file 10)
scores were comparable. The results of linear mixed
model analysis for the continuous and categorical sec-
ondary outcomes are provided in Tables 4 and 5 re-
spectively. Table 6 details the mean within- and
between-group changes from baseline. The results of
these analyses for the behavioural process outcomes are
presented in Additional files 10 and 11. Further explora-
tory analyses of selected outcomes according to specific
joint pain area are detailed in Additional file 12.
Changes in secondary outcomes
There were improvements in the mean scores for most
secondary outcomes at 2 and 6months for the overall
sample and within each diagnostic subgroup, apart from
the WOMAC scores which showed minimal change for
both OA hip and knee participants. There were small
between-group mean differences, apart from the NRS-
pain intensity at 2 months and RMDQ at 6 months
which approached their MCID values in favour of the
UP group. However, the proportion of responders [≥30%
drop from baseline] at 2 months was comparable in both
groups for the RMDQ [UP 57.6%; SOLAS 58.7%] and
NRS-pain intensity scale [UP: 47.1%; SOLAS: 44%].
There was an increase from baseline in both groups in
the proportion of participants engaging in moderate or
high levels of PA and SM behaviours related to physical
activity at all time-points with the group ratio of ORs
favouring SOLAS at all time-points. There was an in-
crease in the proportion of participants using mental re-
laxation techniques only in the SOLAS group with large
group ratios of ORs at 6 weeks (4.34) and 2months
(4.39), while the non-use of pain relief increased at 6
weeks in both groups and continued to rise in the UP
group only, the group ratio of ORs were small at all
time-points. Finally, there were large increases in the
proportion of participants who reported eating healthily
at all time-points in both groups.
Changes in the process model of behavioural change
At 6 weeks, there were improvements in the SDT-based
determinants of SM behaviour with the between-group
mean difference in change from baseline in favour of
SOLAS for the measures of perceived competence
[PCQ-PA mean, 95% CI = − 0.37, − 0.99, 0.25; PCQ-
SM = − 0.46, − 1.07, 0.16], and motivation to participate
in physical activity [BREQ-RAI = − 0.71, − 1.78, 0.36] and
to self-manage [TSRQ-RAI = − 1.19, − 2.96 to 0.59].
There were also small changes at 6 weeks in favour of
SOLAS for pain catastrophising [PCS = − 1.02; − 2.96,
5.00], but in favour of UP for fear (TSK = − 0.71, − 1.99,
0.56). At 2 and 6months, the intervention effects on per-
ceived competence and autonomous motivation grad-
ually reduced, while the effects on controlled and
amotivation remained stable or increased with small
between-group differences in favour of SOLAS at 6
months. Changes in pain catastrophising and fear in-
creased in both groups over time, with small between-
group mean differences evident (Additional file 11).
Discussion
This is the first feasibility trial of a group-based theoret-
ically informed complex self-management intervention
for both OA and chronic LBP that has evaluated its ac-
ceptability alongside testing the proposed trial proce-
dures from the perspectives of both healthcare providers
and patients. Preliminary effects of the intervention were
also explored, as was the proposed process model of be-
haviour change.
Feasibility: acceptability, demand and necessary
adaptations of the SOLAS intervention
The findings of the qualitative interviews and self-report
measures demonstrated that the SOLAS intervention
content, support materials and group-based mode of de-
livery were acceptable and appropriate to participants
with OA and CLBP and physiotherapists alike. These
findings are reinforced by our previous report of high fi-
delity to these elements of the intervention [27]. Feasible
adaptations for a future definitive trial include simplify-
ing the education content of the first session to increase
its acceptability and fidelity and ensuring the materials
are suitable for participants with low health literacy.
Fifty seven percent of participants attended five out of
six SOLAS classes. This is a higher attendance rate than
other RCTs of the 6-week group interventions for CLBP
delivered in the Irish health service [32, 33], and com-
parable to the ESCAPE-knee pain intervention in the
UK health service [15]. However, the small class sizes
with an average of four participants rather than our tar-
get of six and inconsistent participant attendance placed
demands on the practicality of PTs’ delivery of the inter-
vention with high fidelity [27], and thus challenge the
viability of a future definitive trial of this intervention
and its future implementation within the health system,
as discussed below.
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Table 4 Model-predicted mean (95% CI) outcomes per group over time
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Feasibility: trial recruitment, retention and follow-up
procedures
The trial was successful in recruiting 14 clusters demon-
strating the strong partnership between the research
team and PCCC areas established during the develop-
ment phase [13]. Nonetheless, four clusters withdrew
consent after randomisation and treatment allocation for
reasons unforeseen at the outset of the trial (i.e. proxim-
ity to other clusters and non-availability of suitable par-
ticipants), and which are partly due to the time lag of at
least 9 months between randomisation and commence-
ment of the trial in some of these sites. Overall, 21% of
potential participants sent invitation letters were re-
cruited, which is within the range of other trials of
group-based programmes for these populations [15, 32–
35]. Furthermore, the recruitment protocol successfully
enrolled participants with OA of the hip, knee, lumbar
spine and CLBP, with the latter being the most prevalent
in line with population data. In contrast to the FASA
intervention, which restricted recruitment to individuals
with OA aged at least 50 years [12], our findings have
demonstrated the feasibility of enrolling and retaining
younger participants with CLBP to a group-based
programme alongside older people with OA. Nonethe-
less, the average cluster size of five participants in both
arms, the average class size of four participants and the
overall recruitment rate were below the target of 144 re-
quired to demonstrate feasibility, but enough for a sam-
ple size calculation for a definitive trial as discussed
below.
Despite the recruitment protocol being embedded
within the health system and developed in partnership
with PTs [13], several challenges beyond our control
impacted upon its success. First, the research ethics
committee requirement that potentially suitable par-
ticipants contact study staff resulted in a 66% re-
sponse to the invitation letter. Second, the need for
individual participant consent for data collection prior
to enrolment rather than employing a more pragmatic
service-based quality improvement protocol that
would have automatically enrolled all patients at the
cluster level negatively impacted on our ability to
reach our target population. Third, participant re-
cruitment was outside routine PT practice and was
conducted by non-clinical research PTs, thus poten-
tially increasing the complexity for patients in acces-
sing physiotherapy.
Despite increases in the recruitment rate, cluster size
and response to invitation letters across waves as study
procedures were improved, further protocol changes
would be required to ensure recruitment targets and the
optimal class size of six are achievable in any future de-
finitive trial. For example, the time-consuming paper-
based exclusion of most referrals for physiotherapy due
to diagnosis and age is not an effective use of trial re-
sources or feasible for a definitive trial. Recruitment effi-
ciency would be increased if computer-generated
identification codes were available in Ireland’s health
service as in other jurisdictions. Furthermore, despite
high levels of reported participant satisfaction and ac-
ceptability of the SOLAS intervention, some of the main
reasons for excluding participants at the phone screen
stage were their preference for individual PT, their in-
ability to commit to the 6-week class and their poor
English fluency, which challenge the feasibility of a fu-
ture definitive trial within Ireland’s public health system.
The high percentage of potentially suitable participants
expressing a preference for individual treatment is an ac-
curate reflection of the real-world setting in which
SOLAS would be offered to interested patients in future
clinical practice and illustrates that a definitive trial
based on individual patient randomisation would not
have a higher likelihood of successful recruitment than
the cluster design utilised in this feasibility trial. Further
pragmatic obstacles to individual participant randomisa-
tion in a definitive trial are the inconsistency in the
availability of sufficient physiotherapists within these
relatively small PCCC clinics (1–3 musculoskeletal PTs
per clinic) who could provide both treatment arms inde-
pendently, and the need to train 2 PTs per site in the
SOLAS arm to mitigate against frequent maternity, par-
ental, sick and study leave who are not replaced if staff
are absent.
Since the completion of this trial, the importance of
patient and public involvement (PPI) in research has be-
come increasingly recognised in Ireland [36, 37]. There-
fore, the development of a revised recruitment pathway
for a definitive trial would warrant further PPI engage-
ment to address barriers and optimise enablers to par-
ticipation in the group-based class arm in particular
[38–40].
The response rate at 2 months was acceptable, but the
6-month response rate at 72% was below the assumed
loss to follow-up rate of 25%. It is likely that despite the
Table 4 Model-predicted mean (95% CI) outcomes per group over time (Continued)
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Table 6 Mean (95% CI) within- and between-group changes for secondary outcomes
Outcome Group Time
6 weeks 2 months 6 months
SF12-PCS
Score Usual PT 3.68 (1.39, 5.97) 3.71 (1.27, 6.14)
SOLAS 4.18 (1.86, 6.49) 2.26 (−0.18, 4.71)
Group difference: −0.49 (−3.75, 2.76) 1.44 (−2.01, 4.89)
Pain
Intensity (NRS) Usual PT −1.86 (−2.60, −1.13) −1.50 (−2.28, −0.72)
SOLAS −0.96 (−1.71, −0.22) −1.39 (−2.17, −0.60)
Group difference: −0.90 (−1.94, 0.15) −0.11 (−1.22, 0.99)
Bothersomeness Usual PT −0.65 (−0.98, −0.31) −0.61 (−0.96, −0.25)
SOLAS −0.31 (−0.65, 0.02)) −0.29 (−0.65, 0.06
Group difference: −0.33 (−0.81, 0.14)) −0.31 (−0.81, 0.19
RMDQ
Total score Usual PT −4.34 (−6.02, − 2.66) −5.59 (−7.43, −3.76)
SOLAS −3.46 (−5.26, − 1.66) −3.65 (−5.55, − 1.75)
Group difference: −0.88 (−3.35, 1.58) − 1.94 (−4.59, 0.70)
WOMAC function daily living
Hip subscale score Usual PT 1.91 (−3.61, 7.43) 0.88 (−5.03, 6.79)
SOLAS −1.30 (−7.56, 4.96) −2.58 (−8.59, 3.44)
Group difference: 3.21 (−5.13, 11.55) 3.45 (−4.98, 11.89)
Knee subscale score Usual PT −0.32 (−5.33, 4.69) 2.54 (−2.66, 7.73)
SOLAS −0.97 (− 5.44, 3.49) 1.91 (−2.99, 6.81)
Group difference: 0.65 (−6.06, 7.37) 0.63 (−6.51, 7.77)
HADS
Total score Usual PT −2.20 (−3.66, −0.70) − 2.41 (− 3.95, − 0.87)
SOLAS − 3.00 (−4.53, −1.47) −3.36 (−4.97, − 1.74)
Group difference: 0.82 (−1.30, 2.95) 0.95 (−1.29, 3.18)
Anxiety scale Usual PT −1.67 (− 2.57, − 0.77) −1.91 (− 2.85, − 0.97)
SOLAS −2.03 (− 2.96, − 1.10) −2.10 (− 3.09, − 1.12)
Group difference: 0.36 (− 0.93, 1.66) 0.19 (− 1.16, 1.55)
Depression scale Usual PT − 0.55 (− 1.40, 0.30) −0.56 (− 1.44, 0.32)
SOLAS −0.99 (− 1.87, − 0.12) − 1.28 (− 2.21, − 0.36)
Group difference: 0.44 (− 0.78, 1.66) 0.72 (− 0.55, 2.00)
GPE
Total score Usual PT 3.85 (2.98, 4.72) 3.05 (2.14, 3.95)
SOLAS 3.65 (2.77, 4.52) 3.29 (2.36, 4.21)
Group difference: 0.21 (−1.03, 1.44) −0.24 (− 1.53, 1.06)
EQ5D
Weighted Health Index Usual PT + 0.08 + 0.06
SOLAS + 0.01 + 0.04
Group difference: 0.06 0.02
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support of our researcher and the preference of the ma-
jority of respondents for telephone follow-up, the aver-
age 41min to complete it at 2 months and the addition
of the CSRI at 6 months were off putting to some non-
respondents. Therefore, the number of follow-up points
and multiple outcome measures that accounted for each
joint condition and the complex behaviour change
process would need to be reduced to maximise response
rates and optimise follow-up procedures for a future de-
finitive trial as discussed below. Furthermore, an add-
itional strategy to protect against loss to follow-up
would be to offer a telephone interview to collect data
points required for analysis of the primary outcome only,
in the case of participant non-response.
Feasibility: design of a definitive trial
The above findings inform the most efficient and effect-
ive study design for any future definitive trial. Some ex-
pert trialists have raised problems with the cluster trial
design due to compromised concealment of allocation
and improper randomisation (i.e. clusters are recruited
and randomised and then participants are enrolled as
occurred in this feasibility trial causing differential re-
cruitment and imbalance between groups) [41], arguing
in favour of individual participant randomisation [42].
There is no evidence that the SOLAS feasibility trial dis-
played selection bias as the recruitment rate and cluster
size were comparable between arms across the three
study waves, the two arms were balanced at baseline for
all sociodemographic variables for both participants and
physiotherapists and there was minimal crossover from
the intervention to the control arms during the treat-
ment phase (i.e. n = 1 participant), indicating minimal
contamination. Nonetheless, the authors have consid-
ered the feasibility of incorporating recommendations to
cluster trial recruitment processes to minimise these
challenges in the design of a future definitive trial [41].
These include the screening and enrolment of all partici-
pants prior to cluster randomisation or (if this is not
possible) the randomisation of clusters after the enrol-
ment of the first participant. While ideal, these solutions
would be challenging in Ireland’s health system due to
the nature of the SOLAS intervention (i.e. the impossi-
bility of blinding PTs and the 2-month lead in time for
PT training that would cause lengthy waiting times for
participants after cluster randomisation), and the com-
plexity of the multi-stakeholder recruitment process de-
scribed previously. A further recommendation to use
blinded independent recruiters who are separate from
the allocation process [41] could be used in a definitive
trial with greater resources than our feasibility trial
where staff involved in the central recruitment processes
were blinded to the cluster allocation of individual
participants and followed the same protocol regardless
of cluster allocation.
In determining the proposed sample size for a defini-
tive trial based on our secondary outcome results, the
authors selected the SF12-PCS as the primary outcome
with a primary endpoint of 6 months based on other
RCTs of self-management for chronic musculoskeletal
pain and other chronic conditions [43, 44]. The minimal
clinical important change for the SF12-PCS is reported
as 3.2 [45], giving an estimated sample size for a defini-
tive trial using a cluster design with a cluster size of six,
using the observed cluster ICC (conservatively, 0.01) and
estimated standard deviation for baseline-adjusted 6-
month SF12-PCS (8.49), a definitive trial would require
117 participants per arm to achieve 80% power at a type
I error rate of 0.05. A further increase of at least 25% of
this sample size target would be required for retention
at 6 months as discussed above resulting in a recruit-
ment target of 156 participants per arm. Based on the
previously discussed challenges to the recruitment, re-
tention and follow-up of participants in this feasibility
trial at both the cluster and total sample size levels, the
likelihood of reaching this recruitment target in a defini-
tive trial in Ireland’s health system is low.
Changes in secondary outcomes
The finding of comparable small effects for both SOLAS
and individual PT for the majority of secondary out-
comes is consistent with our rapid review [9] and other
systematic reviews of education and exercise SM pro-
grammes for OA [7] and LBP [8]. The larger improve-
ments in pain intensity in the UP group at 2 months and
in LBP-related functional disability at 6 months could be
associated with the multi-modal treatments utilised tar-
geting analgesia, including clinical guideline endorsed
manual therapy [5]. A recent trial of SDT-driven individ-
ual physiotherapy for LBP found limited effects for pain,
function or quality of life compared to usual PT, with
similar group differences to the current study [29]. The
minimal change in the WOMAC-physical function sub-
scale for OA hip or knee participants may reflect its
poor responsiveness compared to other measures or
physical performance tests and warrants omission in any
future definitive trial [46], with the use of only the SF-12
for all diagnostic subgroups to further reduce respond-
ent burden.
The SOLAS intervention maximal dose of 9 h over 6
weeks, which was agreed with PTs during the develop-
ment phase and found to be acceptable in this feasibility
trial, is relatively low compared to other group-based in-
terventions (including FASA) that have shown larger be-
tween and within group effects on pain, function and
quality of life outcomes for OA knee [15, 47, 48]. Con-
versely, clinical LBP guidelines recommend group-based
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exercise programmes that promote self-management but
were unable to recommend the intensity of the
programme [5].
SOLAS process model of behaviour change
The effect of the intervention on LBP-related determi-
nants was minimal, with weak effects in the full sample
for pain catastrophising and no effect on fear at comple-
tion of the 6-week programme [5, 49]. The measurement
of fear avoidance may have been underestimated due to
the use of the 6-item activity avoidance subscale of the
TSK-11 [50] to reduce respondent burden. Nonetheless,
it is proposed that these variables should be removed
from the process map of behaviour change given their
tentative evidence, its complexity, and the multi-joint
focus of the intervention.
In line with the assumptions of SDT, there were small
changes in participants’ perceived competence and mo-
tivation for both PA and self-management that favoured
SOLAS at week 6, but these changes alone were not
enough to promote long-term increases in participant
behaviour. These findings are consistent with previous
literature and suggest sustained increases in autonomous
motivation may be required for behaviour change [51,
52]. Although PTs underwent training and were deemed
competent to deliver SOLAS within the feasibility trial,
they struggled to effectively utilise specific strategies re-
lated to goal setting [25, 26]. This is noteworthy as a col-
laborative goal-setting process between a health care
professional and patient is likely to be important in in-
creasing and sustaining a patient’s autonomous motiv-
ation and competence for the particular behaviour [53–
55]. Additionally, some PTs in the qualitative interviews
felt they needed further training to augment their use of
autonomy supportive language (i.e. flexible and suggest-
ive rather than pressurising language) when delivering
SOLAS, an important communication technique for pro-
moting autonomous motivation [56]. This requirement
was reinforced by independent observers who rated PTs’
average use of autonomy supportive language as moder-
ate (4.2 on a 7-point Likert scale) [25].
The small increases found in subjectively measured
PA and in the SM behaviours related to PA within
SOLAS up to 2 months provide preliminary evidence of
its effect on these behaviours. PTs’ overall moderate fi-
delity to the intervention BCTs and their inability to de-
liver all 26 BCTs targeting PA within the trial may have
contributed to these small effects [26]. If a definitive trial
is to take place, first, the core intervention BCTs must
be identified and second, training enhancements are re-
quired to target PTs’ use of particular BCTs.
The limitation of self-report measures of PA is well
recognised in the literature, due to recall bias, social de-
sirability bias and poor correlation with objective
measures [57]. There is currently no evidence that an in-
crease in self-reported PA is associated with improve-
ments in pain and disability outcomes for OA [57] and
LBP [58], but the quality of current research is low, the
majority of current interventions lack a strong theoret-
ical basis and have failed to evaluate treatment fidelity
and the findings of the current study shed some light on
these elements for future interventions targeting PA.
The higher use of mental relaxation techniques in the
SOLAS group at 2 and 6months may reflect the greater
focus on the uptake of these skills within the interven-
tion and may be associated with the consistent small re-
ductions in HADS subscale scores in favour of SOLAS,
suggesting the relatively short time focusing on this SM
skill could be increased given the moderate levels of
anxiety and depression of the sample at baseline. Con-
versely, the marginally lower use of pain relief tech-
niques in the UP group at 2 and 6months could be
related to the greater reduction in pain intensity at 2
months in this group.
The major strengths of this feasibility trial relate to the
use of a comprehensive range of quantitative and quali-
tative methods and the inclusion of a high number of
clusters across a range of sites and geographical areas to
address clearly defined feasibility objectives and a priori
criteria for moving to a definitive trial from both partici-
pant and PT perspectives. The design of the feasibility
trial was guided by the MRC framework, underpinned
by behaviour change theory and extensive stakeholder
engagement, and its reporting conforms to CONSORT
guidelines for feasibility [24] and cluster trials [59] (see
Additional file 13). There were also some limitations
that should be acknowledged including the unforeseen
withdrawal of consent of four clusters after treatment al-
location, below target recruitment rate and the high
number of secondary outcomes that probably contrib-
uted to the below expected response rate at 6 months.
While adherence to the intervention SM skills (apart
from specific exercise) was measured by an unvalidated
researcher-designed questionnaire, consistent with many
similar studies [60], the qualitative participant interviews
of participants enactment of SM skills supported these
findings and could contribute to its future validation. A
self-report measure was used to assess participant PA,
and the inclusion of a user-friendly low-cost objective
measure of PA in any future definitive trial is warranted.
It was not possible to blind participants or PTs due to
the nature of the study, and we did not interview partici-
pants who did not complete the 6-month follow-up or
those with low attendance rates.
Conclusions
The findings have demonstrated that the complex,
group-based, theory-driven SOLAS intervention is
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acceptable to PTs and patients with OA and CLBP and
has preliminary evidence of small effects on the second-
ary outcomes and the process map of behaviour change
comparable to individual physiotherapy in its current
format and dose. Minor changes to the intervention con-
tent, underpinning process model, BCTs and PT training
programme have been identified to optimise its design,
uptake and delivery for evaluation in a definitive trial.
However, the likelihood of recruiting enough partici-
pants for a definitive cluster trial in Ireland’s current pri-
mary care service is low given the significant constraints
on participant identification, recruitment and enrolment
procedures identified in this study thus rendering a de-
finitive trial unfeasible.
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continuing care; PCQ-PA: Perceived Competence Questionnaire for physical
activity; PCQ-SM: Perceived Competence Questionnaire for self-management;
PCS: Pain Catastrophising Scale; PPI: Patient and public involvement;
PT: Physiotherapy/physiotherapist; RMDQ: Roland Morris Disability
Questionnaire; SDT: Self-determination theory; SF12-PCS: Short Form-12 Phys-
ical Component Score; SM: Self-management; SOLAS: Self-management of
osteoarthritis and low back pain through activity and skills; SMBQ: Self-
management Behaviour Questionnaire; TSRQ: Treatment Self-Regulation
Questionnaire; TSK-11: Tampa Scale of Kinesiophobia Activity Avoidance
Subscale; UP: Usual individual physiotherapy; W: Wave; WOMAC: Western
Ontario and McMaster Universities Arthritis Index
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